Table 4

Barriers and facilitators to implementation of dermoscopy and teledermoscopy

AspectQuoted as barrier in:Type of studyQuoted as facilitator in:Type of study
Training requirementsChappuis et al 38 SurveyPagnanelli et al 30 DA study
Morris et al 40 Survey
van der Heijden et al 37 Cohort study
Cost*Chappuis et al 38 SurveyKoelink et al 24*RCT
Morris et al 39 SurveyRosendahl et al 25 Cohort study
Moreno-Ramirez et al 36 DA studyFerrándiz et al 26*RCT
Livingstone and Solomon41*Case series
Time consumptionChappuis et al 38 SurveyBörve et al 34 Case–control
Moreno-Ramirez et al 36 DA study
van der Heijden et al 37 Cohort study
Reimbursement for offering dermoscopy services (in USA)Morris et al 39 Survey
Equipment issuesvan der Heijden et al 37 Cohort studyBörve et al 34 Case–control
Moreno-Ramirez et al 36 DA study
Reduced referralsChappuis et al 38 Survey
Koelink et al 24 RCT
Börve et al 34 DA study
Moreno-Ramirez et al 36 DA study
Early detection of melanomaChappuis et al 38 Survey
Reduced patient anxietyChappuis et al 38 Survey
Reduced physician anxietyChappuis et al 38 Survey
Moreno-Ramirez et al 36 DA study
Menzies et al 14 DA study
  • *Based on studies where a cost-effective analysis was undertaken.

  • DA, diagnostic accuracy; RCT, randomised controlled trial.